Inside Health

BBC Radio 4
Inside Health

Series that demystifies health issues, separating fact from fiction and bringing clarity to conflicting health advice.

  1. 19 NOV

    Can supervised toothbrushing fix the children's dental crisis?

    In the UK, around a third of British children have tooth decay. Just among the under-fives, it's a quarter - a figure that rises significantly in the most deprived areas. Tooth decay can cause speech development issues, embarrassment for children and in 2023, 15 million school days were missed due to tooth pain or treatment. There’s a financial cost too – in 2023 in England alone tooth extractions under a general anaesthetic cost the NHS £41 million. And it's totally preventable. So, how can we stop teeth rotting in the first place? One way initiative announced by the new Labour government is to expand supervised toothbrushing sessions to more children. We find out how these work with Oral Health Team Lead Helen Bullingham who supports nurseries and schools in East Sussex to deliver these programmes. But what about the evidence to support this intervention? Zoe Marshman, Professor of Dental Public Health at University of Sheffield, explains her findings and dental hygienist and researcher at King's College London Dr Claire McCarthy describes what parents should be doing, in an ideal world, at home. And finally, what role does sugar play and how can we get consumption down? Dr Nina Rogers from the Population Health Innovation Lab at the London School of Hygiene & Tropical Medicine explains her findings into the impact of the Sugar Drinks Industry Levy introduced in 2018. Presenter: James Gallagher Producers: Hannah Robins Content Editor: Holly Squire Inside Health is a BBC Wales & West production for Radio 4, produced in partnership with The Open University.

    28 min
  2. 5 NOV

    What next for Alzheimer's treatment?

    The first drugs to slow Alzheimer's progression have been making headlines around the world. For researchers in the field, the arrival of these two therapies called Lecanemab and Donanemab is testament to decades of advancements in the field of Alzheimer's research because for the first time they go further than modifying the symptoms and have been shown in trials to slow down cognitive decline. For patients and families these treatments offer hope that the amount of quality time they'll have together could be lengthened. Around the world regulatory bodies are weighing up their effectiveness, safety and cost. In the UK by the Medicines and Healthcare products Regulatory Agency (MHRA) has approved Lecanemab and Donanemab for use but the National Institute for Health and Care Excellence (NICE) rejected them for use in the NHS on the basis the benefit to patients did not outweight the cost, although they could still be available privately. Presenter James Gallagher examines the decision with Professor of Public Health Carol Brayne from the University of Cambridge and neuroscientist Professor Tara Spires-Jones from the University of Edinburgh. Then, looking forward, he meets scientists searching for future treatments including Dr Emma Mead, chief scientist at the Alzheimer's UK Drug Discovery Institute at the University of Oxford, Dr Ashvini Keshavan, co-lead of University College London's ADAPT blood biomarker trial, Selina Wray, Professor of Molecular Neuroscience and Alzheimer's Research UK Senior Research Fellow at University College London, and UK Dementia Research Institute Emerging Leader Dr Claire Durrant. This programme was produced in partnership with The Open University. Presenter: James Gallagher Producer: Tom Bonnett Editor: Holly Squire

    28 min
  3. 29 OCT

    Focus on the breath

    Have you ever thought about how you breathe? For many of us, the 20,000+ breaths we take each day go underneath our conscious awareness. But every now and then, a short-lived spout or a chronic case of breathlessness can remind us just how vital good breathing is for our health. But can we all breathe “better”? Some wellness trends suggest so... James Gallagher gets to grips with mouth-taping: the practice of taping the mouth shut during the night to promote exclusive ‘nasal breathing’. Many claim it has improved their sleep, their athletic performance and even given them a more chiselled jaw. Ken O’Halloran, professor of physiology at University College Cork, explains what research has been done looking into this trend and warns about when taping might do more harm than good. James also visits The Coliseum in Covent Garden to hear how an operatic training programme has improved the quality of life for people living with Long-COVID. ENO Breathe, designed by The English National Opera and Imperial College Healthcare NHS Trust, has seen 4000 people learn to breathe like a classical singer to help them handle breathlessness. Creative director, Suzi Zumpe, and respiratory registrar, Keir Philip, talk through the programme and its impacts. Finally, could taking consciousness control of our breathing for a short time each day improve our health? Guy Fincham, researcher at the University of Sussex, dives into his PhD research on breathwork, including his initial studies looking at who might benefit from these practices. Presenter: James Gallagher Producer: Julia Ravey Content Editor: Holly Squire Studio Engineer: Giles Aspen Production Coordinator: Ismael Soriano This programme was produced in partnership with The Open University.

    28 min

Ratings & Reviews

5
out of 5
3 Ratings

About

Series that demystifies health issues, separating fact from fiction and bringing clarity to conflicting health advice.

More From BBC

You Might Also Like

To listen to explicit episodes, sign in.

Stay up to date with this show

Sign in or sign up to follow shows, save episodes and get the latest updates.

Select a country or region

Africa, Middle East, and India

Asia Pacific

Europe

Latin America and the Caribbean

The United States and Canada